CLN5 and Brain atrophy: Affected animals exhibit a human CLN5 disease-like phenotype including progressive brain atrophy and loss of vision from 11 to 12 months of age, and a shortened life span of <22 months (Jolly et al., 2002; Frugier et al., 2008).